Cabot (NYSE:CBT) Announces FY 2027 Earnings Guidance

Cabot (NYSE:CBT) updated its FY 2027 earnings guidance on Tuesday. The company provided earnings per share guidance of 6.150-6.750 for the period, compared to the consensus earnings per share estimate of 7.030.

Analyst Ratings Changes

Several brokerages have recently issued reports on CBT. Weiss Ratings reaffirmed a “hold (c)” rating on shares of Cabot in a research report on Friday, August 21st. Wall Street Zen raised shares of Cabot from a “hold” rating to a “buy” rating in a report on Sunday, October 11th. UBS Group reduced their price target on shares of Cabot from $86.00 to $80.00 and set a “neutral” rating for the company in a research report on Wednesday. JPMorgan Chase & Co. raised their price objective on shares of Cabot from $70.00 to $78.00 and gave the stock an “underweight” rating in a report on Friday, August 7th. Finally, Truist Financial lowered their price objective on shares of Cabot from $100.00 to $95.00 and set a “buy” rating on the stock in a research report on Wednesday. Two equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat.com, the company currently has a consensus rating of “Hold” and an average price target of $85.60.

Cabot Stock Performance

NYSE:CBT opened at $75.18 on Thursday. The company has a quick ratio of 0.97, a current ratio of 2.16 and a debt-to-equity ratio of 0.67. The business’s 50-day moving average price is $77.38 and its two-hundred day moving average price is $79.53. The stock has a market cap of $3.88 billion, a P/E ratio of 18.75, a PEG ratio of 9.30 and a beta of 0.83. Cabot has a twelve month low of $58.33 and a twelve month high of $94.53.

Cabot (NYSE:CBT) last posted its quarterly earnings data on Monday, November 2nd. The specialty chemicals company reported $1.61 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $1.55 by $0.06. Cabot had a net margin of 5.69% and a return on equity of 19.64%. The company had revenue of $1.01 billion during the quarter, compared to the consensus estimate of $927.29 million. During the same period in the previous year, the firm posted $1.70 EPS. The firm’s revenue was up 12.2% compared to the same quarter last year. As a group, equities analysts predict that Cabot will post 6.45 EPS for the current fiscal year.

Insider Buying and Selling at Cabot

In related news, CEO Sean Keohane sold 134,895 shares of Cabot stock in a transaction that occurred on Friday, August 28th. The stock was sold at an average price of $85.00, for a total transaction of $11,466,075.00. Following the sale, the chief executive officer directly owned 404,134 shares in the company, valued at $34,351,390. The trade was a 25.03% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which is available through this hyperlink. In the last 90 days, insiders sold 229,597 shares of company stock valued at $19,646,746. 3.08% of the stock is currently owned by company insiders.

Cabot News Roundup

Here are the key news stories impacting Cabot this week:

• Positive Sentiment: Truist lowered its price target to $95 from $100 but maintained a Buy rating, implying substantial upside from the cited share price. Truist target update
• Positive Sentiment: Cabot beat fourth-quarter EPS and revenue estimates, with revenue of $1.01 billion versus expectations of about $927 million. Battery-materials expansion was also cited as part of the company’s growth case. Cabot earnings and valuation analysis
• Neutral Sentiment: UBS cut its target to $80 from $86 and kept a Neutral rating, indicating a more cautious view while still placing its target above the cited share price. UBS target update
• Negative Sentiment: Cabot forecast fiscal 2027 adjusted EPS of $6.15–$6.75, below the cited consensus estimate of $7.03. The company also expects $200 million–$230 million in capital expenditures, while reports noted weaker margins despite the earnings beat. Fiscal 2027 outlook and capex

About Cabot

Cabot Corporation (NYSE: CBT) is a global specialty chemicals and performance materials company headquartered in Boston, Massachusetts. The company develops and manufactures materials used to improve the performance, durability, conductivity, color and purity of products across a range of industries.

Cabot’s products include carbon black used in tires, rubber goods, coatings, plastics and printing inks; specialty carbons and conductive materials for batteries and other applications; and specialty compounds and masterbatches.